SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-323714
Filing Date
2021-11-09
Accepted
2021-11-09 06:57:59
Documents
14
Period of Report
2021-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d231353d8k.htm   iXBRL 8-K 25175
2 EX-99.1 d231353dex991.htm EX-99.1 76503
6 GRAPHIC g231353g85f13.jpg GRAPHIC 7715
  Complete submission text file 0001193125-21-323714.txt   255290

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cgem-20211109.xsd EX-101.SCH 2916
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cgem-20211109_lab.xml EX-101.LAB 20374
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cgem-20211109_pre.xml EX-101.PRE 12771
7 EXTRACTED XBRL INSTANCE DOCUMENT d231353d8k_htm.xml XML 3718
Mailing Address ONE MAIN STREET SUITE 520 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 520 CAMBRIDGE MA 02142 617-410-4650
Cullinan Oncology, Inc. (Filer) CIK: 0001789972 (see all company filings)

IRS No.: 813867811 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39856 | Film No.: 211389814
SIC: 2836 Biological Products, (No Diagnostic Substances)